These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9090872)
1. Three new cryptophycins from Nostoc sp. GSV 224. Subbaraju GV; Golakoti T; Patterson GM; Moore RE J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872 [TBL] [Abstract][Full Text] [Related]
2. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224. Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864 [TBL] [Abstract][Full Text] [Related]
3. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins. Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938 [TBL] [Abstract][Full Text] [Related]
4. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues. Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479 [TBL] [Abstract][Full Text] [Related]
5. "Clicktophycin-52": a bioactive cryptophycin-52 triazole analogue. Nahrwold M; Bogner T; Eissler S; Verma S; Sewald N Org Lett; 2010 Mar; 12(5):1064-7. PubMed ID: 20131817 [TBL] [Abstract][Full Text] [Related]
6. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues. Eissler S; Bogner T; Nahrwold M; Sewald N Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734 [TBL] [Abstract][Full Text] [Related]
7. Tasipeptins A and B: new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp. Williams PG; Yoshida WY; Moore RE; Paul VJ J Nat Prod; 2003 May; 66(5):620-4. PubMed ID: 12762794 [TBL] [Abstract][Full Text] [Related]
8. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides. Shih C; Teicher BA Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266 [TBL] [Abstract][Full Text] [Related]
9. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts. Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975 [TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines. Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816 [TBL] [Abstract][Full Text] [Related]
11. Ulongapeptin, a cytotoxic cyclic depsipeptide from a Palauan marine cyanobacterium Lyngbya sp. Williams PG; Yoshida WY; Quon MK; Moore RE; Paul VJ J Nat Prod; 2003 May; 66(5):651-4. PubMed ID: 12762800 [TBL] [Abstract][Full Text] [Related]
12. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608 [TBL] [Abstract][Full Text] [Related]
13. Enantioselective synthesis of (+)-cryptophycin 52 (LY355703), a potent antimitotic antitumor agent. Ghosh AK; Swanson L J Org Chem; 2003 Dec; 68(25):9823-6. PubMed ID: 14656116 [TBL] [Abstract][Full Text] [Related]
15. Bioactivity profiling using HPLC/microtiter-plate analysis: application to a New Zealand marine alga-derived fungus, Gliocladium sp. Lang G; Mitova MI; Ellis G; van der Sar S; Phipps RK; Blunt JW; Cummings NJ; Cole AL; Munro MH J Nat Prod; 2006 Apr; 69(4):621-4. PubMed ID: 16643039 [TBL] [Abstract][Full Text] [Related]
16. Recent approaches for the synthesis of modified cryptophycins. Weiss C; Sammet B; Sewald N Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943 [TBL] [Abstract][Full Text] [Related]
17. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies. Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors. Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of cryptophycin 52 using the Shi epoxidation. Hoard DW; Moher ED; Martinelli MJ; Norman BH Org Lett; 2002 May; 4(10):1813-5. PubMed ID: 12000306 [TBL] [Abstract][Full Text] [Related]